Pharmacokinetics (PK) Mice Study- Award Notice
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Centers for Disease Control and Prevention (CDC), under the Department of Health and Human Services, has issued a Special Notice announcing the award of contract 75D30125P20589 for a Pharmacokinetics (PK) Mice Study. The contract, valued at $36,300.00, was awarded to NORTHEAST BIOANALYTICAL LABORATORIES LLC on August 20, 2026. This notice is published for informational purposes to correct an administrative oversight and provide public transparency regarding the award.
Scope of Work
The awarded contract pertains to a Pharmacokinetics (PK) Mice Study, which involves research and development services focused on understanding the absorption, distribution, metabolism, and excretion of substances within mice. This work falls under the Product Service Code AJ13 (General Science & Technology R&D Svcs; General Science & Technology; Experimental Development).
Contract Details
- Awarded To: NORTHEAST BIOANALYTICAL LABORATORIES LLC
- Award Date: August 20, 2026
- Value: $36,300.00
- Set-Aside: Total Small Business Set-Aside (FAR 19.5)
- Agency: Centers for Disease Control and Prevention (CDC)
- Place of Performance: Atlanta, GA, United States
- Published: January 28, 2026
Purpose of Notice
This notice is issued solely for informational purposes and does not constitute a solicitation for new offers or responses. It is posted after the fact to rectify an administrative oversight and ensure public transparency concerning the contract award. No response or action is requested from interested parties.